PAPER Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, Garringer HJ, Cullinane PW, Saito Y, Foroud T, Warner TT, Hasegawa K, Vidal R, Murayama S, Revesz T, Ghetti B, Hasegawa M, Lashley T, Scheres SH, Goedert M
SEARCH RESULTS
229120 RESULTS
PAPER Krafft G, Hefti F, Goure W, Jerecic J, Iverson K, Walicke P
O2–06–03: ACU-193: A candidate therapeutic antibody that selectively targets soluble beta-amyloid oligomers
Alzheimer's & Dementia, July 2013 . Alzheimer's & DementiaPAPER Ma K, Martinez-Losa MM, Xue YQ, Khan A, Ho K, Dodart JC, Jerecic J, Cobos I, Palop JJ
P2-063: Soluble Aβ-Oligomer–Selective Antibody Acu-3b3 Reduces Amyloid Pathology and Improves Multiple Behavioral Domains in a Mouse Model of Alzheimer's Disease
Alzheimer's & Dementia, 1 July 2019 . Alzheimer's & DementiaPAPER Tai HC, Ma HT, Huang SC, Wu MF, Wu CL, Lai YT, Li ZL, Margolin R, Intorcia AJ, Serrano GE, Beach TG, Nallani M, Navia B, Jang MK, Tai CY
The tau oligomer antibody APNmAb005 detects early-stage pathological tau enriched at synapses and rescues neuronal loss in long-term treatments
bioRxiv. June 26, 2022 . bioRxivPAPER Norambuena A, Sagar VK, Wang Z, Raut P, Feng Z, Wallrabe H, Pardo E, Kim T, Alam SR, Hu S, Periasamy A, Bloom GS
Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APPSAA knock-in mouse model of Alzheimer disease
bioRxiv2024.02.02.578668 .PAPER Gunasekaran TI, Meena D, Lee AJ, Wu S, Dumitrescu L, Sperling R, Hohman TJ, AlzheimersDiseaseNeuroimagingInitiativeandtheA4Study, Huang J, Dehghan A, Tzoulaki I, Mayeux R, Vardarajan B
Genome-wide scan of Flortaucipir PET levels finds JARID2 associated with cerebral tau deposition
medRxiv2024.10.04.24314853 .PAPER Kumar A, Bansal A, Singh TR
ABCD: Alzheimer's disease Biomarkers Comprehensive Database.
3 Biotech. 2019 Oct;9(10):351. Epub 2019 Sep 3 PubMed.PAPER Ye T, Li X, Zhou P, Ye S, Gao H, Hua R, Ma J, Wang Y, Cai B
Chrysophanol improves memory ability of d-galactose and Aβ25-35 treated rat correlating with inhibiting tau hyperphosphorylation and the CaM-CaMKIV signal pathway in hippocampus.
3 Biotech. 2020 Mar;10(3):111. Epub 2020 Feb 13 PubMed.PAPER Chi H, Tang W, Bai Y
Molecular evidence of impaired iron metabolism and its association with Parkinson's disease progression.
3 Biotech. 2020 Apr;10(4):173. Epub 2020 Mar 19 PubMed.PAPER Tan MA, Lagamayo MW, Alejandro GJ, An SS
Neuroblastoma SH-SY5Y cytotoxicity, anti-amyloidogenic activity and cyclooxygenase inhibition of Lasianthus trichophlebus (Rubiaceae).
3 Biotech. 2020 Apr;10(4):152. Epub 2020 Mar 3 PubMed.PAPER Kundu D, Prerna K, Chaurasia R, Bharty MK, Dubey VK
Advances in protein misfolding, amyloidosis and its correlation with human diseases.
3 Biotech. 2020 May;10(5):193. Epub 2020 Apr 4 PubMed.PAPER Dhanavade MJ, Sonawane KD
Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.
3 Biotech. 2020 Jun;10(6):247. Epub 2020 May 11 PubMed.PAPER Chaubey MG, Patel SN, Rastogi RP, Madamwar D, Singh NK
Cyanobacterial pigment protein allophycocyanin exhibits longevity and reduces Aβ-mediated paralysis in C. elegans: complicity of FOXO and NRF2 ortholog DAF-16 and SKN-1.
3 Biotech. 2020 Aug;10(8):332. Epub 2020 Jul 6 PubMed.PAPER Xuan WT, Wang H, Zhou P, Ye T, Gao HW, Ye S, Wang JH, Chen ML, Song H, Wang Y, Cai B
Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.
3 Biotech. 2020 Aug;10(8):359. Epub 2020 Jul 29 PubMed.PAPER Tan MA, Gonzalez SJ, Alejandro GJ, An SS
Neuroprotective effects of vomifoliol, isolated from Tarenna obtusifolia Merr. (Rubiaceae), against amyloid-beta1-42-treated neuroblastoma SH-SY5Y cells.
3 Biotech. 2020 Oct;10(10):424. Epub 2020 Sep 10 PubMed.Current Filters
- TYPE: Paper x